Kintor cleared to begin Brazilian trial of proxalutamide for hospitalized COVID-19 patients Jan. 29, 2021
Final analysis data presented from BLAZE-1 phase II/III study in mild-to-moderate COVID-19 Jan. 29, 2021
CARB-X funding supports Lumen's development of immunotherapy to prevent diarrheal diseases Jan. 29, 2021
Dosing initiates in phase I study of CORVax12, a unique DNA vaccine candidate against COVID-19 Jan. 28, 2021
RSS